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Abstract
Background: Our previous studies demonstrated that dietary supplementation with milk fat globule membrane
(MFGM) combined with habitual exercise improved muscle strength by stimulating neuromuscular development in
mice. This study aimed to demonstrate the beneficial effects of dietary MFGM supplementation plus regular
exercise on muscle strength and neuromuscular function in healthy humans.
Methods: The study was designed as a randomized, double-blind, placebo-controlled, crossover trial. Fourteen
Japanese adults aged 31–48 years took daily MFGM (1 g) or placebo tablets during the 4-week study period and
attended a training program twice a week. Physical function tests and surface electromyography (EMG) were
conducted at baseline and at the end of the study period.
Results: The MFGM group had significantly greater leg extension strength than the placebo group after the 4-week
study period. Surface EMG showed that the MFGM group had a significantly higher root mean square amplitude
than the placebo group, which indicated that the MFGM group had higher motor unit activity.
Conclusions: Dietary MFGM supplementation combined with regular exercise improves skeletal muscle strength,
which may be due to increased motor unit recruitment in healthy Japanese middle-aged adults.
Background
Muscle strength is an excellent indicator of general
health. Optimal muscle function is important with re-
spect to rehabilitation and quality of life in many muscu-
loskeletal diseases [1–4]. However, starting at the age of
25 years, muscle strength in healthy men decreases in a
linear fashion, losing 54–89 % of its capacity by the age
of 75 years [5]. Therefore, the decline of skeletal muscle
strength in younger aged adults should be prevented to
maintain a higher quality of life in their older age.
Resistance training is well known to increase muscle
mass and strength [6]. However, high-intensity and long-
term resistance training is necessary to achieve satisfactory
improvement of muscle mass and strength. Accordingly,
more efficient strategies that boost the exercise-induced
improvement of skeletal muscles are required to maintain
general health for non-athletes. Nutritional supplementa-
tion may facilitate more efficient muscle improvement for
people lacking exercise or when combined with low-
intensity and low-frequency exercise. Recent studies dem-
onstrated that dietary supplementation with amino acids
[7] or tea catechins [8] significantly improved muscle mass
and strength in the elderly when combined with regular,
low intensity exercise.
Our recent studies in mice have demonstrated that
dietary supplementation with milk fat globule mem-
brane (MFGM), when combined with habitual exercise,
significantly improved muscle mass and strength [9], as
well as swimming endurance capacity [10]. MFGM is
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the structural membrane covering a triglyceride globule
that is dispersed as emulsified bodies in milk [11]. Our
previous study revealed that the beneficial effects of
dietary MFGM on skeletal muscles was associated with
stimulation of neuromuscular junction (NMJ) develop-
ment [9], which is a critical structure of a motor unit (a
single motor neuron and all of the muscle fibers that it
innervates). MFGM supplementation in the diet combined
with voluntary exercise (wheel-running) significantly in-
creased muscle strength and expression of NMJ-related
molecules in adult mice [9]; however, whether nutritional
supplementation with MFGM can facilitate neuromuscu-
lar improvement by regular exercise in humans has yet to
be explored.
The present study aimed to investigate whether dietary
MFGM combined with regular exercise can increase




Fourteen male subjects (aged 31–48 years) were enrolled
in the present study (Table 1). Subjects were excluded if
they had uncontrolled hypertension, coronary heart dis-
ease, or if they engaged in resistance training in their
daily lives. They were instructed not to change their
daily exercise habits or diets during the study period.
Signed informed consent from each subject was ob-
tained after fully informing them about the details and
methods of this study. The study was performed under
the supervision of an occupational health physician, in
accordance with the regulations of the Kao Corporation
Ethics Committee for Internal Clinical Studies and in
conformity with the Declaration of Helsinki.
Randomization and study protocol
The study was designed as a randomized, double-blind,
placebo-controlled, crossover trial. Randomization was
performed after baseline assessment. The randomization
procedure was conducted by a person who was not in-
volved in the study, and the subjects and test staff
remained unaware of the assignments throughout its
duration. The subjects were randomly divided into 2
groups. During the first 4-week intervention period,
one group (n = 7) received placebo tablets and the other
(n = 7) received MFGM tablets. Subjects took test tab-
lets each day during the 4-week period (period 1) and
underwent exercise training twice a week. A 4-week
washout period was followed by a second 4-week inter-
vention period (period 2) in which the groups were re-
versed. Physical function tests were performed at the
beginning and the end of the 4-week intervention. We
assessed the safety of the test tablets by evaluating the
adverse events, discontinuation rate, and vital signs, as
well as by conducting additional laboratory safety tests.
Milk fat globule membrane consumption
Each subject ingested a MFGM tablet (1 g) or a placebo
tablet (1 g whole milk powder) daily for 4 weeks. The
daily dose of MFGM (1 g; equivalent to 600 mL of whole
milk) was chosen based on what is known about its nutri-
tional safety and efficacy, after converting the minimal ef-
fective dose in mice [10] to a human equivalent while
considering the relative body surface areas. On the exercise
training enforcement days, the subjects were instructed to
take the tablet within 1 h before training. On the other
days, the subjects were instructed to consume the tablet at
the time of their choice during their daily routines.
The MFGM was prepared from buttermilk by filtering
and centrifugation. The MFGM and whole milk powder
compositions were analyzed at Japan Food Research
Laboratories (Tokyo, Japan). The composition of the
MFGM and whole milk powder are shown in Table 2.
Table 1 Characteristics of study subjects
Value
Age, year 39.9 ± 1.3
Body weight, kg 69.1 ± 2.7
Body fat ratio, % 18.7 ± 1.5
Whole BMM, kg 52.8 ± 1.3
Leg muscle mass, kg 9.7 ± 0.4
Thigh circumference, cm 46.4 ± 0.9
BMM, body muscle mass
Body weight, body fat ratio, whole body and leg (average of left and right)
muscle mass were measured using a bioimpedance body fat analyzer (BC-621,
Tanita, Co., Tokyo, Japan). Thigh circumference (average of left and right) was
measured 15 cm proximal to the superior pole of the patella
Values are mean ± SEM (n = 14)
Table 2 Composition of MFGM and whole milk powder












MFGM Milk fat globule membrane
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Exercise training
Training was conducted twice weekly on nonconsecutive
days for 4 weeks using StrengthErgo 240 stationary cyc-
ling exercise machines (Mitsubishi Electric Corporation,
Tokyo, Japan). The subjects completed 3 sets of 15 %
maximal voluntary contraction (MVC) cycle exercises
for 60 s and 7 sets of 20 % MVC cycle exercises for 40 s
at 50 rpm.
Physical function test
Physical function testing consisted of anthropometric
measurements, blood analysis, and leg extension strength
tests. Tests were conducted before and after the 4-week
intervention period.
Anthropometric measurements
Body weight, body fat ratio, and muscle mass were mea-
sured using a bioimpedance body fat analyzer (BC-621,
Tanita, Co., Tokyo, Japan). Thigh circumference was mea-
sured 15 cm proximal to the superior pole of the patella.
Blood sampling and analysis
Blood was collected from an intermediate vein of the fore-
arm after an overnight fast for the following serum tests:
aspartate aminotransferase (AST), alanine aminotransfer-
ase (ALT), glucose, triglyceride, and total cholesterol. The
serum samples were analyzed at SRL Inc. (Tokyo, Japan).
The numbers of white blood cells and red blood cells
(RBCs), as well as the hemoglobin concentration, were
measured with an automatic hemocytometer (Celltac
MEK-5258, Nihon Kohden, Tokyo, Japan).
Leg extension strength
The isokinetic extension strength of each leg was the pri-
mary outcome and was measured using the StrengthErgo
240 (Mitsubishi Electric Co., Tokyo, Japan) [12, 13]. Each
subject pedaled the apparatus with maximum effort 5
times. The peak muscle strength of the right and left legs
was calculated as the maximal isokinetic leg extension
strength.
Surface electromyography
Motor unit activity during the exertion of muscle force
was evaluated using surface electromyography (EMG)
[14, 15]. The surface EMG signals of the intermediate
portion of the right vastus medialis were detected during
leg extension strength measurement with the Ambu®
Blue Sensor M (Ambu Ltd., Ballerup, Denmark). After
preparing the skin with an alcohol swab to reduce im-
pedance, an electrode was fixed on the skin surface so
that it ran along the underlying muscle fibers. The
EMG signal was measured using a Bio-monitor
ME6000 (Mega Electronics Ltd., Kuopio, Finland).
After the analog-to-digital conversion, the root mean
square (RMS) amplitude, an indicator of motor unit
activity [16, 17], was calculated using the MegaWin 3.0
software (Mega Electronics Ltd., Kuopio, Finland).
Sample size and statistical analysis
The sample size of this crossover study was based on
our previous study investigating leg extension strength
after exercise intervention, where the goal was to detect
a 5 % change [18]. As we used two-sided tests to achieve
type I error rates of less than 5 %, we determined that
14 subjects would be sufficient to provide a statistical
power of 80 % in these types of studies.
All variables are presented as mean ± SEM. The differ-
ences in study endpoints or the changes from baseline
between interventions were analyzed by using a linear
mixed model. We included the fixed effects of group,
period, period baseline, and the interaction of group and
period. We also included subject as a random effect.
When the model showed a significant intervention ef-
fect, pairwise comparison between interventions was
performed with Bonferroni analysis, and changes were
considered significant at P < 0.05. For statistical analysis,
SPSS for Windows, release 23.0 (SPSS, Chicago, IL) was
used.
Results
Effects on anthropometric values and blood variables
All subjects completed the intervention protocol, and
there were no adverse side effects from the ingestion of
the test tablets. No overall changes in body weight, body
fat ratio, whole body and leg muscle mass, or thigh cir-
cumference were observed during the intervention period
(Table 3).
There were no clinically significant changes in fasting
serum AST, ALT, glucose, triglyceride, or total choles-
terol levels during the 4-week intervention (Table 4).
RBCs and Hemoglobin levels after 4 weeks were signifi-
cantly higher in the MFGM group compared with the
Table 3 Changes in anthropometric variables before and after
the intervention
Baseline 4 weeks
Placebo MFGM Placebo MFGM
Body weight, kg 69.0 ± 2.7 69.5 ± 2.8 69.0 ± 2.7 69.5 ± 2.7
Body fat ratio, % 18.6 ± 1.6 17.7 ± 1.5 18.4 ± 1.6 18.3 ± 1.6
Whole BMM, kg 52.8 ± 1.2 53.8 ± 1.4 52.9 ± 1.2 53.3 ± 1.2
Leg muscle mass, kg 9.7 ± 0.36 9.9 ± 0.38 10.0 ± 0.34 10.0 ± 0.36
Thigh circumference, cm 45.8 ± 0.9 46.2 ± 0.9 45.8 ± 0.8 45.9 ± 0.9
MFGM Milk fat globule membrane, BMM Body muscle mass
Body weight, body fat ratio, whole body and leg (average of left and right)
muscle mass were measured using a bioimpedance body fat analyzer (BC-621,
Tanita, Co., Tokyo, Japan). Thigh circumference (average of left and right) was
measured 15 cm proximal to the superior pole of the patella
Values are mean ± SEM (n = 14). There were no significant differences between
the groups and the changes within each group from baseline
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placebo group, although the mean values did not deviate
from the Japanese standard values (Table 3).
Effect on muscle strength and electromyography
parameters
After the intervention, a significant difference was de-
tected for leg extension strength (Table 5). The strength
in the MFGM group was significantly higher than in the
placebo group at 4 weeks. Moreover, the percent change
from the baseline was significantly higher in the MFGM
group than in the placebo group. Although the baseline
of period 2 was higher than that of period 1 in this
crossover study, this apparent carryover effect after the
washout period was not significant.
The percent change from baseline RMS, an indicator
of motor unit activity during the leg extension strength
measurement, was significantly higher in the MFGM
group than in the placebo group (Table 6).
Discussion
This study had two major findings. The first was that
daily intake of 1 g MFGM combined with regular, twice
weekly exercise improved skeletal muscle strength (leg
extension) in middle-aged adults, despite a lack of
change in muscle mass. The second was that dietary
MFGM supplementation plus regular exercise also in-
creased the RMS of surface EMG, indicating that dietary
MFGM increased motor unit activity during muscle
contraction.
Surface EMG comprises of the sum of the electrical
contributions made by the active motor units, and its
amplitude is related to the net motor unit activity (i.e.,
the recruitment and the discharge rates of the active
motor units) [16, 17]. Improved neurological adaptation
in skeletal muscles has been recognized to provide a lar-
ger proportion of the initial strength increment during
isotonic strength training compared to muscle hyper-
trophy [19]. This muscle reinforcement is accompanied




AST, IU/L Baseline 17.7 ± 1.5 17.1 ± 0.6
4 weeks 17.6 ± 0.8 16.6 ± 0.6 P= 0.354
ALT, IU/L Baseline 14.3 ± 1.8 12.9 ± 1.3
4 weeks 12.4 ± 1.1 11.9 ± 1.0 P = 0.880
Glucose, mg/dL Baseline 96.6 ± 2.1 95.5 ± 3.1
4 weeks 94.3 ± 2.0 97.7 ± 2.5 P = 0.092
Triglyceride, mg/dL Baseline 99.4 ± 9.8 95.3 ± 10.5
4 weeks 92.5 ± 11.1 95.8 ± 9.2 P = 0.397
Total cholesterol,
mg/dL
Baseline 187.9 ± 7.6 179.9 ± 7.7
4 weeks 177.7 ± 6.6 177.3 ± 7.4 P = 0.387
Blood components
WBCs, 102/μL Baseline 49.6 ± 4.1 46.7 ± 3.5
4 weeks 41.9 ± 3.2 46.4 ± 2.9 P = 0.164
RBCs, 104/μL Baseline 503.1 ± 8.3 508.4 ± 8.9
4 weeks 494.0 ± 11.6 520.9 ± 11.1 P = 0.013
Hemoglobin, mg/dL Baseline 15.1 ± 0.2 15.3 ± 0.2
4 weeks 14.8 ± 0.2 16.0 ± 0.3 P < 0.001
MFGM Milk fat globule membrane, AST Aspartate aminotransferase, ALT
Alanine aminotransferase, WBCs White blood cells, RBCs Red blood cells
Blood was collected from an intermediate vein of the forearm after an
overnight fast. The serum samples were analyzed at SRL Inc. (Tokyo, Japan).
The numbers of WBCs and RBCs, as well as the hemoglobin concentrations
were measured with an automatic hemocytometer (Celltac MEK-5258, Nihon
Kohden, Tokyo, Japan)
Values are mean ± SEM of 14 subjects. Differences in study endpoints between
interventions were analyzed by using a linear mixed model, with group,
period, period baseline, and the interaction of group and period as fixed
effects; and subject as a random effect. When the model showed a significant
intervention effect, pairwise comparison between interventions was performed
via Bonferroni analysis. Changes were considered significant if P < 0.05
Table 5 Values of leg extension strength before and after the
intervention
Placebo MFGM P-value
Leg extension strength, Nm Baseline 177.6 ± 7.3 175.8 ± 8.0
4 weeks 175.7 ± 7.3 182.2 ± 7.0 P = 0.001
Change from baseline to 4 weeks, %
4 weeks −0.95 ± 1.2 4.23 ± 1.3 P = 0.001
MFGM Milk fat globule membrane
The leg extension strength was measured using StrengthErgo 240 (Mitsubishi
Electric Co., Tokyo, Japan)
Values are means ± SEM of 14 subjects. Differences in study endpoints
between interventions were analyzed by using a linear mixed model, with
group, period, period baseline, and the interaction of group and period as
fixed effects; and subject as a random effect. When the model showed a
significant intervention effect, pairwise comparison between interventions was
performed via Bonferroni analysis. Changes were considered significant
if P < 0.05
Table 6 Electromyogram results before and after the
intervention
Placebo MFGM P-value
RMS, mV Baseline 0.319 ± 0.035 0.278 ± 0.032
4 weeks 0.293 ± 0.044 0.308 ± 0.034 P = 0.142
Change from baseline to 4 weeks, %
4 weeks −8.92 ± 7.28 12.52 ± 5.80 P = 0.028
MFGM Milk fat globule membrane, RMS Root mean square
The surface EMG signals of the right vastus medialis were detected during leg
extension strength measurement with the Ambu® Blue Sensor M (Ambu Ltd.,
Ballerup, Denmark). The EMG signal was measured using a Bio-monitor
ME6000 (Mega Electronics Ltd., Kuopio, Finland). After the A/D conversion, the
root mean square (RMS) amplitude was calculated using MegaWin 3.0 software
(Mega Electronics Ltd., Kuopio, Finland)
Values are means ± SEM of 12 subjects. Differences in study endpoints
between interventions were analyzed by using a linear mixed model, with
group, period, period baseline, and the interaction of group and period as
fixed effects; and subject as a random effect. When the model showed a
significant intervention effect, pairwise comparison between interventions was
performed via Bonferroni analysis. Changes were considered significant
if P < 0.05
Soga et al. Nutrition Journal  (2015) 14:85 Page 4 of 6
by increased RMS that indicates increased motor unit
recruitment during neurological adaptation. Because the
leg muscle mass did not change after MFGM ingestion
in the present study, increased muscle strength by diet-
ary MFGM supplementation appears to be due to the in-
crease in motor unit activity such as recruitment.
Pathway analysis after transcriptomic measurement in
our previous study [9] revealed that dietary MFGM com-
bined with regular exercise improved muscle strength in
adult mice primarily by stimulating the pathway involving
“nervous system development” in the skeletal muscle. This
pathway includes functional annotations such as forma-
tion of synapses, growth of neurites, or development of
NMJ. Dietary MFGM combined with exercise increased
skeletal muscle expression of docking protein-7 (Dok-7)
and muscle-specific receptor tyrosine kinase in mice [9],
both of which play a critical role in NMJ formation
[20, 21]. Defects in NMJ function causes muscle weakness
in neuromuscular disorders, and Dok-7 gene therapy im-
proves NMJ formation and rescues the motor activity [22].
The results in the present study are consistent with the
previous findings and indicate that dietary MFGM plus
exercise increases motor unit recruitment and enhances
muscle strength, probably owing to neuromuscular
mechanisms.
In this study, the semi-weekly exercise alone did not
increase muscle strength in the placebo group. This may
be due to the moderate intensity of the training, which
challenged only 15–20 % of their leg extension strength.
Nevertheless, nutritional supplementation with MFGM
significantly boosted muscle strength in middle-aged
adults completing this moderate intensity semi-weekly
exercise.
We also observed increased RBCs and hemoglobin
levels after dietary supplementation with MFGM. This
result is consistent with our previous findings in mice
[9]. The reason for the increased RBCs and hemoglobin
after MFGM ingestion was unclear. MFGM is abundant
in phospholipids that are critical components of the
plasma membrane (Table 2). Decreased phospholipid
content in the cell membrane of RBCs has been shown
to attenuate the vulnerability of the cells [23], which
may reduce cellular hemoglobin. One possible explan-
ation is that absorbed phospholipids from MFGM might
be incorporated into and stabilize the cell membranes of
RBCs, hence retaining the hemoglobin. In fact, the num-
ber of RBCs tended to increase after MFGM ingestion
for 4 weeks (Table 4). Because increased RBCs and
hemoglobin improves oxygen transport and exercise per-
formance [24], dietary supplementation with MFGM
might also improve endurance capacity in humans.
However, further studies are required to confirm the in-
crease in RBCs and hemoglobin by dietary MFGM and
clarify its underlying mechanism.
Several limitations of the present study should be con-
sidered. First, our sample size was small. Second, the
washout period might be insufficient because the base-
line value of the leg extension strength for period 2 was
still higher than the baseline value for period 1. Third,
the type and intensity of the exercise were also limited.
Therefore, the effects of MFGM alone compared to
those when combined with exercise of various types or
intensities still need to be clarified. Finally, the dose-
dependent nature of the beneficial effects of MFGM on
muscles still requires investigation. Since activity of
motor units varies with exercise intensity and type [25],
we expect that dietary MFGM and exercise training
would improve muscle function additively or synergistic-
ally. Studies comprising of larger cohorts are in progress
to clarify these issues.
In conclusion, this study provides evidence that daily
consumption of 1 g MFGM combined with regular exer-
cise of moderate intensity improves muscle strength
with increased motor unit activity, such as recruitment,
in healthy Japanese middle-aged adult males. One gram
of MFGM corresponds to 600 mL of milk; hence, ab-
sorbing adequate daily amounts of MFGM by consum-
ing milk or dairy products may not be achievable.
Therefore, daily supplementation with MFGM, together
with regular exercise of moderate intensity, may be
beneficial for the improvement of muscle function and
physical performance.
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